Cisbio Bioassays

Codolet, France

Cisbio Bioassays

Codolet, France
SEARCH FILTERS
Time filter
Source Type

Patent
Universitte Of Montpellier, Cisbio Bioassays, Center National Of Le Recherche Sceientifique Cnrs and Institute Jean Paoli & Irene Calmettes | Date: 2015-07-03

The present invention relates to anti-metabotropic glutamate receptor subtype 2 (mGluR2) conformational single do main antibodies and uses thereof in particular in the therapeutic and diagnostic field.


Patent
French National Center for Scientific Research and Cisbio Bioassays | Date: 2017-03-29

The present invention relates to anti-Epidermal Growth Factor Receptor (EGFR) conformational single domain antibodies and uses thereof in particular in the therapeutic and diagnostic field.


Patent
Cisbio Bioassays, French National Center for Scientific Research and University Paris - Sud | Date: 2017-05-10

The present invention relates to anti- metabotropic glutamate receptor subtype 2 (mGluR2) conformational single domain antibodies and uses thereof in particular in the therapeutic and diagnostic field.


The invention relates to a method for quantifying a protein of interest expressed at the surface of a cell or else present in a tissue sample, said method comprising the use of two ligands capable of binding specifically to a domain of said protein.


The invention relates to a method for determining the ability of a candidate antibody to keep a first cell and a second cell close to one another, said method comprising the following steps: The invention also relates to a reagent kit for carrying out this method.


Patent
Cisbio Bioassays and Institute Gustave Roussy | Date: 2013-07-16

The present invention relates to an ex vivo method for determining the susceptibility of a patient suffering from cancer to respond to a therapeutic treatment based on the administration of an antibody specific for the HER2 protein, this method comprising the quantification of HER2-HER2 dimers in a tissue sample from said patient using the FRET technique. The invention also relates to a kit of reagents for implementing this method.


Patent
Cisbio Bioassays | Date: 2014-04-09

The invention relates to compounds of formula: The compounds of the invention are used to detect M6G in biological fluids.


Patent
Cisbio Bioassays | Date: 2012-09-13

The invention relates to a method for detecting the binding of an antibody to an Fc receptor present on the surface of a cell as well as to a method for determining the level of glycosylation of an antibody. The invention also relates to a reagent kit for carrying out these methods.


The invention relates to complexing agents of formula (I): in which A, chrom1, chrom2 and chrom3 are as defined in the description. The invention also relates to the lanthanide complexes obtained from these complexing agents.


Patent
Cisbio Bioassays, French Institute of Health and Medical Research | Date: 2013-07-17

The invention relates to a method for determining if a patient is at risk of increased mortality, said method comprising the step of measuring the level of vasostatin-1 in a biological sample obtained from said patient. The invention also relates to a sandwich immunoassay kit for implementing said method.

Loading Cisbio Bioassays collaborators
Loading Cisbio Bioassays collaborators